Financhill
Back

Baxter International, Inc. Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison

Sell
47

BAX
Baxter International, Inc.

Last Price:
$21.16
Seasonality Move:
1.18%
Buy
67

DRUG
Bright Minds Biosciences, Inc.

Last Price:
$87.96
Seasonality Move:
-40.64%
Sell
47
Baxter International, Inc. (BAX) is a Sell

Is Baxter International, Inc. a Buy, Sell or Hold?

  • The current Baxter International, Inc. [BAX] share price is $20.69. The Score for BAX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • BAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Bright Minds Biosciences, Inc. (DRUG) is a Buy

Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?

  • The current Bright Minds Biosciences, Inc. [DRUG] share price is $90.01. The Score for DRUG is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BAX Stock Price Chart

What is Baxter International, Inc.'s stock price today?

  • The Baxter International, Inc. share price today is $20.69
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BAX is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences, Inc.'s stock price today?

  • The Bright Minds Biosciences, Inc. share price today is $90.01
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight selling pressure.

BAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.33 Buy
Relative Strength Index (14 RSI): 67.58 Buy
Chaikin Money Flow: 10271238 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.5 - 19.8) Buy
Bollinger Bands (100): (18.78 - 23.64) Sell

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.79 Buy
Relative Strength Index (14 RSI): 58.71 Buy
Chaikin Money Flow: -196363 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (75.34 - 89.1) Buy
Bollinger Bands (100): (46.01 - 75.51) Buy

BAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.82 Buy
20-day SMA: 19.3 Buy
50-day SMA: 19 Buy
200-day SMA: 25.33 Sell
8-day EMA: 19.97 Buy
20-day EMA: 19.49 Buy
50-day EMA: 19.75 Buy
200-day EMA: 24.45 Sell

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.17 Buy
20-day SMA: 84.39 Buy
50-day SMA: 70.26 Buy
200-day SMA: 45.73 Buy
8-day EMA: 86.85 Buy
20-day EMA: 82.54 Buy
50-day EMA: 73.48 Buy
200-day EMA: 51.43 Buy

Baxter International, Inc. Earnings Growth & BAX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and an increase next year of $0.16 per share.

Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.03 per share, and a decrease next year of $3.86 per share.

Baxter International, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):